In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli.
AUTOR(ES)
Buesing, M A
RESUMO
The in vitro synergistic activity of aztreonam in combination with piperacillin, moxalactam, cefotaxime, cefoperazone, and amikacin was examined against multiply resistant isolates of the family Enterobacteriaceae and Pseudomonas aeruginosa. Aztreonam in combination with amikacin demonstrated synergy against 71% of the isolates, whereas combinations of aztreonam plus a second beta-lactam demonstrated synergy against 42% of the isolates.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=185492Documentos Relacionados
- In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli.
- In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates.
- Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli.
- Activity of meropenem against antibiotic-resistant or infrequently encountered gram-negative bacilli.
- Synergistic Activity of Trimethoprim and Amikacin Against Gram-Negative Bacilli
